.svg){kind=logo}
Better Patient Outcomes with Epic Language Access Integration
Learn how to improve health outcomes and ensure compliance for individuals with Limited English Proficiency (LEP) with direct language access integration to the Epic Electronic Health Record (EHR) system.
Case Study: Multilingual Retail Marketing
New AI Content Creation Solutions for a Sports and Apparel Giant
Human Expertise Blended With Powerful AI
Lionbridge Aurora AI™ is an AI-first global content platform that increases your multilingual content creation and expands your audience with culturally relevant, hyper-personalized content.
- RESOURCES
Clinical trials localization is a crucial area for pharmaceutical companies. They rely on this step to help them maintain project timelines and ensure regulatory compliance across various countries and states. Localization also ensures documents are accurately translated for better patient and caregiver comprehension. Better comprehension leads to more accurate data collection and better patient outcomes. Solid, effective clinical trial document localization is about more than just translation. It must encompass:
- Translation, including technical and medical terminology
- Cultural adaptation, including local cultural norms and slang
- Readability and plain language, so all participants can understand their materials
- Consistency of messaging
- Ethical considerations, especially the variance in local ethical standards and practices
It’s also important to note that optimizing clinical trials localization isn’t just about choosing the right expertise to meet all these expectations. Choosing the right provider can open up AI-enabled opportunities to complete localization of materials faster and significantly cut costs. Most clinical operations teams are being pressured to streamline their processes, simplify ordering, and deliver quality-first research every time. Lionbridge’s team of life sciences translation experts has been using it to enhance every stage of the production process, building connectivity to CMSs like Veeva Clinical or automating review processes. Read our case study about how a top-ten global pharmaceutical company has partnered with our life sciences translation services team to move their workflows to a Machine Translation (MT) and LLM post-editing model.
The Clinical Trials Localization Challenge
A top-ten global pharmaceutical company came to Lionbridge for help transforming their clinical trials localization. They needed to streamline and cut costs for the localization of tens of thousands of documents annually. In particular, the customer needed help with these mission-critical documents:
- Informed Consent Forms (ICFs)
- Study Start-Up materials (SSU)
- Patient Experience (PX) content
Because it’s a global pharmaceutical company, the customer needed their documents localized into 50 languages, including:
- Belarusian
- Bulgarian
- Chinese
- Croatian
- Czech
- Danish
- Faroese
- French
- German
- Hungarian
- Icelandic
- Italian
- Japanese
- Korean
- Norwegian
- Polish
- Romanian
- Russian
- Serbian
- Slovak
- Spanish
- Swedish
- Ukrainian
Not only did they need it for these common languages, but they also needed documents localized into some rare and indigenous languages, including long-tail ones from sub-Saharan Africa.
An AI-Powered Clinical Trials Localization Solution
Lionbridge’s team offers clinical trials localization expertise, and we also have innovative AI translation tools for life sciences. We helped this pharma giant switch from a traditional, human-only translation workflow to a more time-and cost-efficient AI-powered one. We built a customized MT-focused workflow and combined it with LLM-assisted human post-editing. To ensure compliant AI translation for life sciences, we ensured the output was all certified to ISO 18587 requirements for post-editing of machine translation.
Results of an MT and LLM-Powered Clinical Trials Localization Solution
By switching to an MT and LLM-powered clinical trials localization workflow, Lionbridge helped the customer meet many of their goals without sacrificing quality. Over the three (and counting) years that we worked with this global pharma giant, our localization output was consistently high-quality and suitable for submissions, site activation, and patient-facing use. We always achieved documented compliance with ISO 18587.
This change in workflow dramatically reduced the company’s localization costs. Every year, we saved them 15-20% in localization spend. These savings are compared to prior human-only translation workflows that met equivalent quality levels.
In terms of turnaround time, our new workflow for this customer notably increased efficiency. We delivered our localization 20-25% faster every time. This change enabled quicker site start-up, faster distribution of ICFs and patient materials, and more agile clinical operations across global studies.
In addition to improved costs and turnaround times, Lionbridge’s new clinical trial localization workflows offered the company some operational benefits. These included:
- Standardized workflows
- Better scalability for peak study volumes
- Improved consistency of terminology and style across regions and trial phases
With successful results from this three-year engagement, the customer continues to partner with Lionbridge's clinical trial translation services team.
Get in touch
Need help reducing your localization turnaround times and costs? Want to explore how we can use AI and MT to improve your compliance and patient outcomes? Learn more about our clinical trial material translations. Let’s get in touch.
